Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4240
Journal Title: Sodium-glucose cotransporter 2 inhibitors for chronic kidney disease: Why, when and when not
Authors: Javaid, Muhammad M.
Frederick, Rachel
Itrat, Sheema
Ekladious, Adel
SWH Author: Javaid, Muhammad M.
Keywords: Kidney
Renal
Kidney Disease
Disease
Inhibitors
Chronic
General Practicioners
Issue Date: Dec-2024
Date Accessioned: 2025-03-24T23:33:13Z
Date Available: 2025-03-24T23:33:13Z
Accession Number: 10.31128/AJGP-11-23-7041
Url: https://www1.racgp.org.au/ajgp/2024/supplement-december/sodium-glucose-cotransporter-2-inhibitors-for-chro/
Format Startpage: S15
Source Volume: 53
Issue Number: 12
Database: PubMed
DOI: 10.31128/AJGP-11-23-7041
Abstract: Background: Chronic kidney disease (CKD) is a significant healthcare problem. More advanced stages are associated with increased mortality, morbidity and cost. Instigating measures to slow down disease progression at an early stage can save lives, and millions of dollars of taxpayers' money. Objective: This article aims to provide evidence-based information to general practitioners, aiding the decision to initiate sodium-glucose cotransporter 2 (SGLT2) inhibitors for CKD patients in their day-to-day practice. Discussion: SGLT2 inhibitors have emerged as a promising and safe addition to the renin-angiotensin-aldosterone system blockers for managing CKD. Randomised controlled trials have shown that SGLT2 inhibitors effectively slow CKD progression in both early and more advanced disease stages, regardless of diabetes status. SGLT2 inhibitors can be a valuable additional treatment option for CKD management in primary care and should be considered for most CKD patients.
URI: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4240
Journal Title: Australian Journal of General Practice
ISSN: Print 2208-794X
Online 2208-7958
Type: Journal Article
Appears in Collections:SWH Staff Publications

Files in This Item:
File Description SizeFormat  
AJGP - 2024 - Javaid - Sodium-glucose cotransporter 2 inhibitors for chronic kidney disease.pdf163.05 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing